Cboe UK CHF

Medartis Holding AG (MEDZ.XC)

Compare
65.00
-2.60
(-3.85%)
At close: 4:00:37 PM GMT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.
NameTitlePayExercisedYear Born
Dr. Thomas Straumann Founder & Vice Chairman 291.97k -- 1963
Mr. Matthias Schupp CEO & Member of the Executive Management Board -- -- 1964
Dr. Dirk W. Kirsten Ph.D. CFO & Member of the Executive Management Board -- -- 1968
Ms. Mareike Loch VP of EMEA & Member of Executive Management Board -- -- 1970
Mr. Manuel Schaer CTO & Member of the Executive Board -- -- 1970
Mr. Mario Della Casa COO & Member of Management Board -- -- 1975
Ms. Inge Maes Chief Human Resources Officer & Executive Management Board Member -- -- --
Ms. Anisha Wharton Head of Regulatory Affairs -- -- --

Medartis Holding AG

Hochbergerstrasse 60E
Basel, 4057
Switzerland
41 61 633 34 34 https://www.medartis.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
860

Description

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. It serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.

Corporate Governance

Medartis Holding AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events